C. Juhlin

H. Falhammar, J. Zedenius, C. Juhlin, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance

C. Larsson, W. Kaelin, A. von Kriegsheim, 2019, Proceedings of the National Academy of Sciences.

Riedel's Thyroiditis.

H. Falhammar, C. Juhlin, J. Calissendorff, 2020, The Journal of clinical endocrinology and metabolism.

Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation

C. Juhlin, 2021, Biology.

Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms

A. Stenman, J. Zedenius, C. Juhlin, 2018, Langenbeck's Archives of Surgery.

HRAS mutation prevalence and associated expression patterns in pheochromocytoma

C. Larsson, M. Bäckdahl, P. Söderkvist, 2016, Genes, chromosomes & cancer.

Immunohistochemical NF1 Analysis Does not Predict NF1 Gene Mutation Status in Pheochromocytoma

P. Söderkvist, A. Stenman, O. Gimm, 2015, Endocrine Pathology.

Parafibromin as a Diagnostic Instrument for Parathyroid Carcinoma-Lone Ranger or Part of the Posse?

C. Juhlin, A. Höög, C. Juhlin, 2010, International journal of endocrinology.

A Rare Case of Giant Amyloid Goiter: A Case Report and Review of Literature

C. Juhlin, R. Bränström, F. Karlsson, 2019 .

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer

S. Mane, C. Larsson, H. Helgadottir, 2022, Biomedicines.

Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight

J. Hartman, C. Larsson, C. Juhlin, 2015, Endocrine connections.

Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.

A. Stenman, R. Korah, T. Carling, 2019, Journal of the American College of Surgeons.

Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma.

Yongsheng Huang, C. Larsson, W. Lui, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Overview of the 2022 WHO Classification of Parathyroid Tumors

A. Gill, L. Erickson, A. Perren, 2022, Endocrine Pathology.

Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: An important tool for improved patient follow-up

J. Zedenius, C. Juhlin, C. Volpe, 2019, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?

C. Juhlin, 2020, Cancer drug resistance.

Genetic characterization of large parathyroid adenomas

C. Larsson, J. Hashemi, C. Juhlin, 2012, Endocrine-related cancer.

Overexpression of cytochrome P450 2A6 in adrenocortical carcinoma

C. Larsson, Timothy D. Murtha, R. Korah, 2017, Surgery.

Absence of KMT2D/MLL2 mutations in abdominal paraganglioma

R. Lifton, K. Bilguvar, G. Goh, 2016, Clinical endocrinology.

Inflammatory infiltrates in parathyroid tumors

C. Larsson, B. Hallström, C. Juhlin, 2017, European journal of endocrinology.

Prolactin Receptor in Primary Hyperparathyroidism – Expression, Functionality and Clinical Correlations

C. Larsson, C. Juhlin, A. Höög, 2012, PloS one.

Parathyroid carcinoma arising from four-gland hyperplasia.

J. Phay, J. T. Broome, C. Juhlin, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Regional differences in somatostatin receptor 2 (SSTR2) immunoreactivity is coupled to level of bowel invasion in small intestinal neuroendocrine tumors.

J. Zedenius, C. Juhlin, A. Höög, 2018, Neuro endocrinology letters.

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis

C. Larsson, U. Scholl, W. Knoefel, 2017, BMC Cancer.

Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones

C. Larsson, C. Juhlin, A. Höög, 2016, European journal of endocrinology.

Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant TERT promoter methylation, but not hot-spot mutations

C. Larsson, Dawei Xu, J. Zedenius, 2019, Epigenetics.

Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature

J. Zedenius, C. Juhlin, F. Haglund, 2020, Journal of Medical Case Reports.

DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinoma.

A. Stenman, R. Korah, T. Carling, 2016, Surgery.

Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours

C. Larsson, A. Arnold, C. Juhlin, 2011, Virchows Archiv.

Metastatic Pheochromocytomas and Abdominal Paragangliomas

H. Falhammar, D. Granberg, C. Juhlin, 2021, The Journal of clinical endocrinology and metabolism.

Somatostatin Receptor Expression in Renal Cell Carcinoma—A New Front in the Diagnostics and Treatment of Renal Cell Carcinoma

I. Shabo, C. Juhlin, A. Höög, 2018, Clinical genitourinary cancer.

Advances in Adrenal and Extra-adrenal Paraganglioma: Practical Synopsis for Pathologists.

C. Juhlin, O. Mete, 2022, Advances in anatomic pathology.

Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance

H. Falhammar, C. Juhlin, I. Bancos, 2022, Cancers.

Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell–Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells

C. Larsson, J. Zedenius, A. Lundqvist, 2014, Clinical Cancer Research.

Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions

C. Larsson, J. Lehtiö, M. Pernemalm, 2015, PloS one.

Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors

C. Larsson, P. Kharchenko, Q. Deng, 2021, Nature Communications.

Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry

A. Stenman, J. Zedenius, I. Shabo, 2019, SAGE open medical case reports.

Overview of the 2022 WHO Classification of Thyroid Neoplasms

M. Papotti, S. Asa, Z. Baloch, 2022, Endocrine Pathology.

Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors

C. Larsson, W. Lui, L. Ährlund‐Richter, 2017, Cell Death & Disease.

Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion

B. Delahunt, H. Samaratunga, L. Egevad, 2020, Head and Neck Pathology.

Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years

H. Falhammar, J. Zedenius, C. Juhlin, 2020, Endocrine Pathology.

On the Chopping Block: Overview of DICER1 Mutations in Endocrine and Neuroendocrine Neoplasms.

C. Juhlin, 2022, Surgical pathology clinics.

GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours

C. Larsson, W. Lui, A. Stenman, 2020, Endocrine-related cancer.

Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin

J. Zedenius, C. Juhlin, A. Höög, 2020, Endocrine Pathology.

Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8

J. Zedenius, N. Rafati, Johan O Paulsson, 2021, The Journal of clinical endocrinology and metabolism.

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma

C. Larsson, M. Bäckdahl, J. Lehtiö, 2016, Oncotarget.

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Annabelle L. Fonseca, S. Mane, C. Larsson, 2015, The Journal of clinical endocrinology and metabolism.

Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma

A. Stenman, Minjun Yang, J. Zedenius, 2021, Cancers.

Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features

A. Stenman, J. Zedenius, C. Juhlin, 2021, Histopathology.

Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry

C. Juhlin, C. Juhlin, 2021, Endocrine Pathology.

Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice

L. Erickson, C. Juhlin, 2020, Endocrine Pathology.

Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature

K. Jatta, J. Zedenius, C. Juhlin, 2020, Head and Neck Pathology.

Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes

C. Larsson, W. Lui, Satendra Kumar, 2019, International journal of cancer.

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression

C. Larsson, A. Stenman, Dawei Xu, 2018, Oncogene.

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours

C. Larsson, J. Nordenström, C. Juhlin, 2010, PloS one.

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

S. Mane, C. Larsson, D. Rimm, 2015, Human molecular genetics.

Institutional characterisation of water clear cell parathyroid adenoma: a rare entity often unrecognised by TC-99m-sestamibi scintigraphy.

H. Falhammar, J. Zedenius, C. Juhlin, 2021, Pathology.

Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center

A. Stenman, Kristina Lagerstedt-Robinson, C. Juhlin, 2019, Modern Pathology.

Cyto‐morphological features of parathyroid lesions: Fine‐needle aspiration cytology series from an endocrine tumor referral center

H. Falhammar, J. Zedenius, C. Juhlin, 2021, Diagnostic cytopathology.

Parathyroid Adenoma With Respiratory-Like Epithelium: Case Report of a Potential Mimic With Unknown Etiology

J. Zedenius, C. Juhlin, 2021, Frontiers in Endocrinology.

Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report

I. Shabo, C. Juhlin, A. Höög, 2018, International journal of surgical pathology.

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors

C. Larsson, J. Lehtiö, J. Hashemi, 2016, The Journal of clinical endocrinology and metabolism.

Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases

C. Larsson, A. Stenman, K. Jatta, 2023, Diagnostic cytopathology.

Evidence of a functional estrogen receptor in parathyroid adenomas.

Inga-Lena Nilsson, Johan Hartman, J. Hartman, 2012, The Journal of clinical endocrinology and metabolism.

TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.

C. Larsson, M. Bäckdahl, A. Stenman, 2018, International Journal of Molecular Medicine.

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features

C. Larsson, Shi-Yong Neo, Dawei Xu, 2022, Cancers.

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma

C. Larsson, Dawei Xu, Xiaotian Yuan, 2020, Cancers.

Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma

C. Larsson, A. Stenman, J. Zedenius, 2018, Clinical endocrinology.

Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion

R. Korah, T. Carling, N. Nicolson, 2020, Endocrine Pathology.

Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics

A. Stenman, K. Jatta, J. Zedenius, 2019, Diagnostic Pathology.

TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up

C. Larsson, A. Stenman, K. Jatta, 2019, Endocrine Pathology.

Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.

A. Stenman, J. Zedenius, C. Juhlin, 2019, Surgery.

Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior

C. Larsson, P. Söderkvist, A. Stenman, 2019, The American journal of surgical pathology.

Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene

Jenny Welander, Gerald Goh, Stefano Caramuta, 2015, Genes, chromosomes & cancer.

The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas—A Meta-Analysis and Systematic Review of the Literature

A. Stenman, J. Zedenius, C. Juhlin, 2019, Cancers.

TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?

C. Larsson, A. Stenman, C. Juhlin, 2023, Endocrine Pathology.

TERT promoter mutations are rare in parathyroid tumors.

C. Larsson, M. Prasad, A. Stenman, 2015, Endocrine-related cancer.

Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma

H. Falhammar, A. Stenman, C. Juhlin, 2019, Journal of the Endocrine Society.

Soft Tissue Metastasis of Parathyroid Carcinoma: Description of a Difficult Case

D. López-Presa, S. Vale, C. Juhlin, 2015 .

Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinoma.

G. Goh, A. Stenman, R. Korah, 2016, Surgery.

Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case

A. Stenman, K. Jatta, J. Zedenius, 2020, Endocrine Pathology.

Minimally invasive follicular thyroid carcinomas: prognostic factors

C. Larsson, J. Zedenius, C. Lundgren, 2016, Endocrine.

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index

C. Juhlin, C. Hedman, J. Siikanen, 2021, Cancers.

Pan-genomic characterization of high-risk pediatric papillary thyroid carcinoma

A. Stenman, J. Zedenius, P. Stålberg, 2021, Endocrine-related cancer.

The 2022 WHO Classification of thyroid tumors: novel concepts in nomenclature and grading.

Z. Baloch, C. Juhlin, O. Mete, 2022, Endocrine-related cancer.

Solid Cell Nests Within a Parathyroid Gland—Report of an Exceptional Case

C. Juhlin, A. Höög, I. Nilsson, 2018, Endocrine Pathology.

Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?

A. Stenman, J. Zedenius, C. Juhlin, 2022, Endocrine Pathology.

Extensive Bilateral Adrenal Rest Testicular Tumors in a Patient With 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency

H. Falhammar, A. Nordenström, E. Lolis, 2018, Journal of the Endocrine Society.

Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission

H. Falhammar, C. Juhlin, M. Kjellman, 2020, BMC Gastroenterology.

Riedel’s thyroiditis: clinical presentation, treatment and outcomes

H. Falhammar, S. Catrina, C. Juhlin, 2018, Endocrine.

Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes

C. Larsson, S. Vale, F. Ferreira, 2012, Familial Cancer.

Progress in Adrenal Cortical Neoplasms: From Predictive Histomorphology to FLCN-Driven Germline Pathogenesis and the Prognostic Performance of Multiparameter Scoring Systems in Pediatric Adrenal Cortical Neoplasms

C. Juhlin, O. Mete, 2023, Endocrine Pathology.

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis

C. Larsson, U. Scholl, W. Knoefel, 2017, BMC Cancer.

Adrenal cysts: an emerging condition

H. Falhammar, A. Sundin, C. Juhlin, 2023, Nature Reviews Endocrinology.

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?

A. Stenman, J. Zedenius, Johan O Paulsson, 2021, Thyroid Research.

Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma

R. Lifton, C. Nelson-Williams, G. Goh, 2016, BMC Cancer.

Characteristics, Treatment, Outcomes, and Survival in Neuroendocrine G1 and G2 Pancreatic Tumors: Experiences From a Single Tertiary Referral Center

H. Falhammar, C. Juhlin, R. Bränström, 2021, Frontiers in Endocrinology.

Papillary thyroid carcinoma with pleomorphic tumor giant cells in a pregnant woman – a case report

J. Zedenius, Johan O Paulsson, C. Juhlin, 2018, BMC Endocrine Disorders.

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer

C. Larsson, J. Zedenius, I. Shabo, 2023, Scientific Reports.

Clear Cell Variant of Papillary Thyroid Carcinoma With Associated Anaplastic Thyroid Carcinoma: Description of an Extraordinary Case

C. Juhlin, A. Höög, 2019, International journal of surgical pathology.

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up

K. Jatta, Vincenzo Condello, C. Juhlin, 2023, European thyroid journal.

Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer

P. Grybäck, C. Lundgren, C. Juhlin, 2023, Endocrine.

Top 10 Histological Mimics of Neuroendocrine Carcinoma You Should Not Miss in the Head and Neck

C. Juhlin, M. Bal, C Christofer Juhlin, 2023, Head and Neck Pathology.

Parafibromin and APC as Screening Markers for Malignant Potential in Atypical Parathyroid Adenomas

C. Larsson, C. Juhlin, A. Höög, 2010, Endocrine pathology.

Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism

Murim Choi, R. Lifton, U. Scholl, 2015, eLife.

Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?

A. Stenman, C. Juhlin, Adam Stenman, 2023, Cancers.

Non-functioning neuroendocrine pancreatic tumors transforming to malignant insulinomas - four cases and review of the literature.

C. Juhlin, L. Juntti-Berggren, J. Calissendorff, 2019, Neuro endocrinology letters.

Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma.

C. Larsson, R. Branca, J. Lehtiö, 2010, Thyroid.

Long-term storage of endocrine tissues at - 80°C does not adversely affect RNA quality or overall histomorphology.

C. Juhlin, C. Juhlin, A. Höög, 2013, Biopreservation and biobanking.

Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series.

H. Falhammar, J. Zedenius, C. Juhlin, 2023, Endocrine.

Distinguishing between thyroid and parathyroid nodules by ultrasound: a potential game-changer in clinical practice?

J. Zedenius, C. Juhlin, Jan Zedenius, 2023, The Lancet regional health. Europe.

Lung Carcinoids: A Comprehensive Review for Clinicians

H. Falhammar, D. Granberg, C. Juhlin, 2023, Cancers.

Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell–Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells

C. Larsson, J. Zedenius, A. Lundqvist, 2014, Clinical Cancer Research.

Atrophic changes in thyroid tumors are strong indicators of underlying DICER1 mutations: a bi-institutional genotype-phenotype correlation study.

C. Juhlin, K. Viswanathan, Catharina Larsson, 2024, Virchows Archiv.

Prevalence, Molecular Landscape and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules.

J. Zedenius, Vincenzo Condello, Johan O Paulsson, 2024, The Journal of clinical endocrinology and metabolism.

DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinoma.

R. Korah, T. Carling, J. Rubinstein, 2016, Surgery.

Painting the path to precision: unraveling endocrine tumors with immunohistochemistry

C. Juhlin, L. S. Hellgren, 2024, Diagnostic Histopathology.

TERT promoter mutations are rare in parathyroid tumors.

C. Larsson, M. Prasad, R. Korah, 2015, Endocrine-related cancer.

The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation.

L. Moens, Suman Ghosal, B. Skogseid, 2024, Journal of Pathology.